FDA Watch: Zepto Life Technology Receives FDA Breakthrough Designation for Blood-Based Mold Test
Its FungiFlex assay can make determining the cause of fungal infections vastly more accurate
Already a member? Log in here
CLIA-lca
Subscribe today for access to
Articles and Reports
New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
Brief Your CEO: After 36 Years, CLIA Comes Under CMS Review
From – G2 Compliance Advisor
Even as your lab makes the transition to the new, supposedly market-based PAMA Medicare Part B fee schedule for tests, big changes may be in store for another rock of…
Already a member? Log in here
CLIA Corner: FDA Moves to Boost CLIA Waiver Transparency
...
Already a member? Log in here
Theranos Faces New Challenges and Increasing Federal Scrutiny
...
Already a member? Log in here
CMS Issues Deficiency Letter to Theranos
...
Already a member? Log in here
FDA’s 2016 Guidance Plans Include LDTs and Other Diagnostics Topics
...
Already a member? Log in here
FDA and CMS Address LDT Regulation Before Energy and Commerce Committee
...
Already a member? Log in here
AMP Offers Proposal for Regulation of Laboratory Developed Tests
...
Already a member? Log in here
Outcome of LDT Regulation Controversy Defies Forecasting
...
Already a member? Log in here
Don’t Overlook Free Resources When Preparing Your Laboratory for ICD-10
...
Already a member? Log in here